Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
West German Study Group
University of Alberta
Ain Shams University
The Methodist Hospital Research Institute
Sunnybrook Health Sciences Centre
AC Camargo Cancer Center
ChineseAMS
Assiut University
Tata Memorial Hospital
University of Minnesota
Leiden University Medical Center
Hospital San Carlos, Madrid
Celgene
Novartis
Optimal Health Research
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
Centre Francois Baclesse
Novartis
Peking Union Medical College Hospital
Royal Marsden NHS Foundation Trust
GBG Forschungs GmbH
Federal University of São Paulo
University of Michigan
Danish Cancer Society
Dexa Medica Group
Pierian Biosciences
Fudan University
University of California, San Diego
Novartis
University of Wisconsin, Milwaukee
Norwegian Breast Cancer Group